Skip to NavigationSkip to content

Ebola

GSK Ebola vaccine underway

GSK image

Clinical trials of an experimental vaccine against the deadly Ebola virus will begin soon according to its developers GlaxoSmithKline.

The news follows an update by a spokesman for the World Health Organization who told a French radio station that trials begin in September, with the vaccine ready to roll-out by 2015 all being well. 

US doctor infected with Ebola as disease spreads

WHO director-general Dr Margaret Chan has warned about the continued spread of the virus

An American doctor working with Ebola patients in Liberia has been infected with the virus as health officials struggle to combat the spread of fatal disease.

Reports by Reuters say that Dr Kent Brantly recognised his symptoms and confined himself to an isolation ward at a hospital in the Liberian capital Monrovia.

The disease has killed at least 672 people in four West African countries since the outbreak began in February in Guinea, having now spread to Liberia and Sierra Leone, making it the world's deadliest outbreak to date.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches